证券代码：300078 证券简称：思创医惠 公告编号：2025-117 思创医惠科技股份有限公司 第六届董事会第十四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 二、董事会会议审议情况 一、董事会会议召开情况 思创医惠科技股份有限公司（以下简称"公司"）第六届董事会第十四次会 议于 2025 年 12 月 3 日在浙江省杭州市滨江区月明路 567 号"医惠中心"23 楼 会议室以现场表决和通讯表决相结合的方式召开。会议通知于 2025 年 11 月 28 日通过电子邮件、电话方式送达各位董事。本次会议应出席董事 8 人，实际出席 董事 8 人。因公司董事许益冉先生已向董事会辞去董事长职务，经董事会过半数 的董事共同推举，本次会议由董事魏乃绪先生召集并主持，公司高级管理人员列 席了会议。本次会议的召集、召开和表决程序符合《中华人民共和国公司法》（以 下简称"《公司法》"）等法律法规和《公司章程》的规定。 （3）将第六届董事会薪酬与考核委员会委员叶肖剑先生调整为何毅琦先生。 1、审议通过了《关于选举第六届董事会董事长、代表公司执行公司事务的 董事 ...

Core Insights - The DRG/DIP concept sector experienced a decline of 0.89%, ranking among the top losers in the market [1] - Notable stocks within the sector included Langchao Software, Jiayuan Technology, and Digital Certification, which saw significant declines, while Shichuang Medical, Taiji Co., and Saili Medical were among the few that increased in value [1] Market Performance - The top-performing concept sectors included Smart Speakers (+3.71%), AI Phones (+3.39%), and Zinc Metals (+2.86%), while the DRG/DIP sector was among the laggards with a decline of 0.89% [2] - The DRG/DIP sector faced a net outflow of 311 million yuan, with 17 stocks experiencing net outflows, and 9 stocks seeing outflows exceeding 10 million yuan [2] Key Stocks and Fund Flow - Langchao Software led the outflow with a net withdrawal of 148 million yuan, followed by Rongke Technology and Shichuang Medical with outflows of 53.22 million yuan and 32.94 million yuan, respectively [2][3] - Conversely, Taiji Co., Weining Health, and Guoxin Health were the top gainers in terms of net inflow, attracting 41.91 million yuan, 16.34 million yuan, and 7.48 million yuan, respectively [2] Detailed Stock Movements - Langchao Software saw a decline of 6.01% with a turnover rate of 22.29% and a net outflow of 147.51 million yuan [2][3] - Other notable declines included Rongke Technology (-2.50%), Shichuang Medical (+4.18%), and Donghua Software (-0.20%) [2][3] - Taiji Co. and Weining Health showed positive movements with increases of 1.60% and 1.28%, respectively, while Guoxin Health remained stable with a slight decrease of 0.20% [2][3]

Group 1 - The core viewpoint of the news is that 思创医惠's stock has experienced fluctuations, with a recent decline of 2.20% and a total market value of 4.45 yuan per share, amounting to 49.75 billion yuan [1] - The company has seen a year-to-date stock price increase of 46.38%, but a recent decline of 8.81% over the last five trading days [1] - The company has been listed on the龙虎榜 five times this year, with the most recent occurrence on November 19 [1] Group 2 - As of September 30, the number of shareholders for 思创医惠 is 58,400, a decrease of 11.34% from the previous period [2] - For the period from January to September 2025, the company achieved a revenue of 604 million yuan, representing a year-on-year growth of 6.95% [2] - The company reported a net profit attributable to shareholders of -4.76 million yuan, showing a year-on-year increase of 98.32% [2] Group 3 - Since its A-share listing, 思创医惠 has distributed a total of 532 million yuan in dividends, with no dividends paid in the last three years [3]

Core Viewpoint - The stock price of Sichuang Medical has increased significantly this year, with a notable rise in recent trading days, indicating strong market interest and potential growth in the healthcare technology sector [2]. Group 1: Stock Performance - Sichuang Medical's stock price has risen by 54.61% year-to-date, with a 4.21% increase in the last five trading days, a 32.02% increase over the last 20 days, and a 27.37% increase over the last 60 days [2]. - The company has appeared on the stock market's "Dragon and Tiger List" five times this year, with the most recent appearance on November 19 [2]. Group 2: Company Overview - Sichuang Medical, established on November 21, 2003, and listed on April 30, 2010, is based in Hangzhou, Zhejiang Province, and focuses on smart hospital solutions, disease research management, and AI services in healthcare [2]. - The company's revenue composition includes 53.84% from real estate sales, 39.28% from business intelligence, and 6.87% from smart healthcare [2]. - Sichuang Medical is classified under the computer-IT services industry and is associated with various concepts such as DRG, family doctor, and new retail [2]. Group 3: Financial Performance - For the period from January to September 2025, Sichuang Medical reported a revenue of 604 million yuan, reflecting a year-on-year growth of 6.95%, while the net profit attributable to shareholders was -4.76 million yuan, showing a significant year-on-year improvement of 98.32% [2]. - As of September 30, the number of shareholders was 58,400, a decrease of 11.34% from the previous period, while the average circulating shares per person increased by 12.79% to 19,077 shares [2]. Group 4: Dividend Information - Since its A-share listing, Sichuang Medical has distributed a total of 532 million yuan in dividends, with no dividends paid in the last three years [3].

Core Viewpoint - The company, Sichuang Medical (300078), focuses on commercial intelligence business, providing IoT solutions for various industries, emphasizing digital retail and supply chain management [1] Group 1: Business Overview - The main business of the company is commercial intelligence, based on the development and production of EAS and RFID technologies [1] - The company aims to change lives through the concept of "Internet of Things" and offers integrated hardware and software services [1] Group 2: Industry Applications - The company provides deep applications of IoT solutions in sectors such as unmanned retail, smart loss prevention, clothing supply chain, and smart cities [1] - The solutions are designed to facilitate digital retail and comprehensive supply chain management [1] Group 3: Future Plans - The company is considering a name change, which will be evaluated based on strategic development plans, business layout, and regulatory requirements [1] - Any necessary disclosures regarding the name change will be made in accordance with legal regulations [1]

Core Viewpoint - The company has transitioned its main business focus from smart medical services to commercial intelligence, specifically in the field of chip technology and IoT solutions [1] Group 1: Business Transition - The company has officially divested its smart medical business and is now concentrating on commercial intelligence [1] - The new business model is based on EAS and RFID development, providing IoT solutions for various industries such as unmanned retail, smart loss prevention, clothing supply chain, and smart cities [1] Group 2: Future Plans - The company is considering a name change to better reflect its current business focus, but this will depend on strategic development plans, business layout, and regulatory requirements [1] - Any future disclosures regarding the name change will be made in compliance with legal and regulatory obligations [1]

Core Viewpoint - The AI medical sector experienced a significant increase of 3.48% on November 24, with leading stock performance from Sichuang Medical [1] Group 1: Market Performance - On November 24, the Shanghai Composite Index closed at 3836.77, up 0.05%, while the Shenzhen Component Index closed at 12585.08, up 0.37% [1] - The top-performing stocks in the AI medical sector included Sichuang Medical, which rose by 8.20% to a closing price of 4.88, and Chengdu Xian Dao, which increased by 6.61% to 22.90 [1] Group 2: Trading Volume and Capital Flow - The AI medical sector saw a net inflow of 136 million yuan from institutional investors, while retail investors contributed a net inflow of approximately 99.92 million yuan [1] - The trading volume for Sichuang Medical reached 2.345 million shares, with a transaction value of 1.11 billion yuan [1] Group 3: Individual Stock Capital Flow - Notable net inflows from institutional investors included 67.19 million yuan for Weining Health, 38.08 million yuan for Rundar Medical, and 33.69 million yuan for Jiuyuan Yinhai [2] - Conversely, retail investors showed net outflows in several stocks, including 47.88 million yuan for Weining Health and 55.12 million yuan for Jiuyuan Yinhai [2]

Core Viewpoint - The internet healthcare sector experienced a rise of 1.26% on November 24, with Focus Technology leading the gains, while the overall market indices showed modest increases [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 3836.77, up 0.05%, and the Shenzhen Component Index closed at 12585.08, up 0.37% [1]. - Focus Technology (002315) saw a significant increase of 9.20%, closing at 48.30, with a trading volume of 224,800 shares and a transaction value of 1.053 billion [1]. - Other notable performers included Sichuang Medical (300078) with an 8.20% increase, closing at 4.88, and Jiahe Meikang (688246) with a 6.45% increase, closing at 24.42 [1]. Group 2: Capital Flow - The internet healthcare sector experienced a net outflow of 89.6577 million from institutional investors, while retail investors saw a net inflow of 763 million [2]. - The leading stocks in terms of net inflow from retail investors included Focus Technology with a net outflow of 97.1479 million, and Jiahe Meikang with a net inflow of 46.0728 million [3]. - The overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are actively participating [2][3].

Core Viewpoint - The medical information technology sector experienced a rise of 1.48% on November 24, with Hengyin Technology leading the gains [1] Group 1: Market Performance - The Shanghai Composite Index closed at 3836.77, up 0.05%, while the Shenzhen Component Index closed at 12585.08, up 0.37% [1] - Hengyin Technology saw a closing price of 12.36, with a significant increase of 9.96% and a trading volume of 403,100 shares, amounting to a transaction value of 485 million [1] - Other notable performers included: - Jiao Dian Technology: closed at 48.30, up 9.20% with a transaction value of 1.053 billion [1] - Sichuang Medical: closed at 4.88, up 8.20% with a transaction value of 1.11 billion [1] - Hongjing Technology: closed at 63.49, up 8.16% with a transaction value of 740 million [1] Group 2: Capital Flow - The medical information technology sector saw a net inflow of 19.8573 million from institutional investors, while retail investors contributed a net inflow of 466.1 million [2] - Notable capital flows included: - Jiao Dian Technology: institutional net inflow of 2.32 billion, retail net outflow of 971.479 million [3] - Jishi Media: institutional net inflow of 172 million, retail net outflow of 1.96 billion [3] - Hengyin Technology: institutional net inflow of 1.62 billion, retail net outflow of 898.739 million [3]

Market Overview - On November 20, the IT services sector declined by 0.22%, with the Shanghai Composite Index closing at 3931.05, down 0.4%, and the Shenzhen Component Index at 12980.82, down 0.76% [1] Top Performers - The top gainers in the IT services sector included: - *ST Yun Chuang: Closed at 12.22, up 15.61% with a trading volume of 128,900 shares and a turnover of 155 million yuan - Junyi Digital: Closed at 25.94, up 14.27% with a trading volume of 353,300 shares and a turnover of 924 million yuan - Qingyun Technology: Closed at 67.65, up 10.76% with a trading volume of 162,800 shares and a turnover of 416 million yuan - Other notable gainers included Wantong Technology, Liujisoft, and Chuling Information, all showing significant increases in share price [1] Underperformers - The leading decliners in the IT services sector included: - Sichuang Medical: Closed at 4.42, down 8.87% with a trading volume of 1,803,300 shares and a turnover of 81.2 million yuan - C South Network: Closed at 22.00, down 7.91% with a trading volume of 1,254,900 shares and a turnover of 2.844 billion yuan - Meideng Technology: Closed at 63.62, down 7.70% with a trading volume of 29,000 shares and a turnover of 18.8 million yuan - Other notable decliners included Inspur Software and Guangyun Technology, both experiencing significant drops in share price [2] Capital Flow - On the same day, the IT services sector saw a net outflow of 1.214 billion yuan from institutional investors, while retail investors contributed a net inflow of 1.574 billion yuan [2][3] - The capital flow for specific stocks showed that: - Changshan Beiming had a net inflow of 342 million yuan from institutional investors, while it experienced a net outflow of 128 million yuan from retail investors - Junyi Digital saw a net inflow of 198 million yuan from institutional investors, with significant outflows from both retail and speculative investors [3]